Business Success


.

Hospitals hit back on drug pricing, but will they knock out the problem?

  • Written by Ernst Berndt, Professor of Management, MIT Sloan School of Management
Hospitals hit back on drug pricing, but will they knock out the problem?Heather Bresch, CEO of Mylan, holds two EpiPens as she testified before Congress Sept. 21, 2016 about rising costs of the drug.AP Photo/Pablo Martinez Monsivais

Drug manufacturing and pricing vaulted into the news several years ago when a privately held company raised the price of a drug used for infections from US$13.50 to $750 for one pill.

After...

Read more: Hospitals hit back on drug pricing, but will they knock out the problem?

More Articles ...

  1. Pakistan's activist Supreme Court endangers a fragile democracy
  2. Baby bust: 5 charts show how expensive it is to have kids in the US today
  3. Why it's so hard to #DeleteFacebook: Constant psychological boosts keep you hooked
  4. The tragic story of America's only native parrot, now extinct for 100 years
  5. Trump plan to execute 'big drug pushers' will do nothing to stop opioid overdoses
  6. Who is John Bolton and what does he want?
  7. Trump's go-it-alone approach to China trade ignores WTO's better way to win
  8. What the staff does matters more than what's in an organization's mission statement
  9. Kids' fitness is improving, but they still aren't as fit as their parents were
  10. Babe Ruth in a kimono: How baseball diplomacy has fortified Japan-US relations
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more

Business Marketing